首页> 外文期刊>Proteomics >Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure
【24h】

Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure

机译:初步研究确定了肌球蛋白重链7,结蛋白,胰岛素样生长因子7和膜联蛋白A2作为人类心力衰竭的循环生物标记

获取原文
获取原文并翻译 | 示例
           

摘要

In-depth proteomic analyses offer a systematic way to investigate protein alterations in disease and, as such, can be a powerful tool for the identification of novel biomarkers. Here, we analyzed proteomic data from a transgenic mouse model with cardiac-specific overexpression of activated calcineurin (CnA), which results in severe cardiac hypertrophy. We applied statistically filtering and false discovery rate correction methods to identify 52 proteins that were significantly different in the CnA hearts compared to controls. Subsequent informatic analysis consisted of comparison of these 52 CnA proteins to another proteomic dataset of heart failure, three available independent microarray datasets, and correlation of their expression with the human plasma and urine proteome. Following this filtering strategy, four proteins passed these selection criteria, including myosin heavy chain 7, insulin-like growth factor-binding protein 7, annexin A2, and desmin. We assessed expression levels of these proteins in mouse plasma by immunoblotting, and observed significantly different levels of expression between healthy and failing mice for all four proteins. We verified antibody cross-reactivity by examining human cardiac explant tissue by immunoblotting. Finally, we assessed protein levels in plasma samples obtained from four unaffected and four heart failure patients and demonstrated that all four proteins increased between twofold and 150-fold in heart failure. We conclude that MYH7, IGFBP7, ANXA2, and DESM are all excellent candidate plasma biomarkers of heart failure in mouse and human.
机译:深入的蛋白质组学分析提供了一种系统的方法来研究疾病中的蛋白质变化,因此,它可以成为鉴定新型生物标志物的有力工具。在这里,我们分析了具有激活的钙调神经磷酸酶(CnA)的心脏特异性过表达的转基因小鼠模型的蛋白质组数据,这会导致严重的心脏肥大。我们应用了统计过滤和错误发现率校正方法,以识别与对照组相比在CnA心脏中有显着差异的52种蛋白质。随后的信息分析包括将这52种CnA蛋白与另一个心力衰竭的蛋白质组学数据集,三个可用的独立微阵列数据集进行比较,以及它们的表达与人血浆和尿液蛋白质组的相关性。按照这种过滤策略,四种蛋白质通过了这些选择标准,包括肌球蛋白重链7,胰岛素样生长因子结合蛋白7,膜联蛋白A2和结蛋白。我们通过免疫印迹评估了这些蛋白质在小鼠血浆中的表达水平,并观察到健康小鼠和衰竭小鼠中四种蛋白质的表达水平明显不同。我们通过免疫印迹检查人心脏外植体组织来验证抗体的交叉反应性。最后,我们评估了从四名未患病和四名心力衰竭患者获得的血浆样品中的蛋白质水平,并证明了所有四种蛋白质在心力衰竭中均增加了两倍至150倍。我们得出的结论是,MYH7,IGFBP7,ANXA2和DESM都是小鼠和人类心力衰竭的优秀候选血浆生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号